AI 32557/AI/NIAID NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1995	7
1996	4
1997	7
1998	4
1999	3
2000	3
2001	6
2002	6
2003	1
2004	1
2022	0

1

Immunoassays for indoor allergens.

Chapman MD, Vailes LD, Ichikawa K. Chapman MD, et al. Clin Rev Allergy Immunol. 2000 Jun;18(3):285-300. doi: 10.1385/CRIAI:18:3:285. Clin Rev Allergy Immunol. 2000. PMID: 10981261 Review. No abstract available.

2

Cockroach allergens: environmental distribution and relationship to disease.

Arruda LK, Ferriani VP, Vailes LD, Pomés A, Chapman MD. Arruda LK, et al. Curr Allergy Asthma Rep. 2001 Sep;1(5):466-73. doi: 10.1007/s11882-001-0035-1. Curr Allergy Asthma Rep. 2001. PMID: 11892074 Review.

3

Recombinant allergens for diagnosis and therapy of allergic disease.

Chapman MD, Smith AM, Vailes LD, Arruda LK, Dhanaraj V, Pomés A. Chapman MD, et al. J Allergy Clin Immunol. 2000 Sep;106(3):409-18. doi: 10.1067/mai.2000.109832. J Allergy Clin Immunol. 2000. PMID: 10984358 Review.

4

Molecular biology of indoor allergens.

Smith AM, Pomes A, Chapman MD. Smith AM, et al. Clin Rev Allergy Immunol. 2000 Jun;18(3):265-83. doi: 10.1385/CRIAI:18:3:265. Clin Rev Allergy Immunol. 2000. PMID: 10981260 Review. No abstract available.

5

Recombinant mite allergens. New technologies for the management of patients with asthma.

Chapman MD, Smith AM, Vailes LD, Arruda LK. Chapman MD, et al. Allergy. 1997 Apr;52(4):374-9. doi: 10.1111/j.1398-9995.1997.tb01014.x. Allergy. 1997. PMID: 9188916 Review.

6

Recombinant allergens for immunotherapy.

Chapman MD, Smith AM, Vailes LD, Pomés A. Chapman MD, et al. Allergy Asthma Proc. 2002 Jan-Feb;23(1):5-8. Allergy Asthma Proc. 2002. PMID: 11894735 Review.

7

Monitoring allergen exposure in asthma: new treatment strategies.

Chapman MD, Heymann PW, Sporik RB, Platts-Mills TA. Chapman MD, et al. Allergy. 1995;50(25 Suppl):29-33. doi: 10.1111/j.1398-9995.1995.tb04273.x. Allergy. 1995. PMID: 7677231 Review.

8

Home allergen monitoring and control--improving clinical practice and patient benefits.

Chapman MD, Tsay A, Vailes LD. Chapman MD, et al. Allergy. 2001 Jul;56(7):604-10. doi: 10.1034/j.1398-9995.2001.00049.x. Allergy. 2001. PMID: 11421917 Review. No abstract available.

9

Immunochemical and molecular methods for defining and measuring indoor allergens: in dust and air.

Chapman MD, Smith AM, Slunt JB, Vailes LD, Arruda LK. Chapman MD, et al. Pediatr Allergy Immunol. 1995;6 Suppl 7:8-12. doi: 10.1111/j.1399-3038.1995.tb00378.x. Pediatr Allergy Immunol. 1995. PMID: 8574324 Review. No abstract available.

10

Identification of a novel cat allergen--cystatin.

Ichikawa K, Vailes LD, Pomés A, Chapman MD. Ichikawa K, et al. Int Arch Allergy Immunol. 2001 Jan-Mar;124(1-3):55-6. doi: 10.1159/000053667. Int Arch Allergy Immunol. 2001. PMID: 11306925

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results